Organic Chemistry TRIZ Cases

Merging neuraminidase and polymerase inhibition into single imino-ribose compounds reduces viral titers while preventing drug resistance.

Ester-linked NSAID-EGFR coupling compounds overcome resistance and reduce toxicity by merging COX-2 and kinase inhibition mechanisms.

Esterified furan derivatives replace petroleum phthalates in surface coverings, reducing migration while maintaining performance.

Substituting carboxyl groups with specific acid labile structures controls acid diffusion to resolve the trade-off between resolution and sensitivity.

A furfural production process uses a water-miscible solvent and acid catalyst to achieve high conversion at atmospheric pressure.

Phenyl acetamide compounds modulate IL-17A activity to resolve the trade-off between oral absorption and treatment efficacy in inflammatory disease therapy.

Formula I compounds target the HCV NS5B protein to inhibit viral replication, addressing limited efficacy and severe side effects of current therapies.

Phenol compounds with polymeric substituents scavenge free radicals, preventing oxidative degradation and reducing migration.

Uracil compounds inhibit dUTPase to reverse drug resistance and improve chemotherapy efficacy.

Perhalide ionic liquids dissolve metals without external oxidants, eliminating safety hazards from hazardous reagents.

Ester-containing phenolic antioxidants preserve elastomeric seal integrity by preventing shrinkage and leakage, ensuring reliable mechanical device operation.

Substituted pyrimidine compounds inhibit Tyk2 kinase to control inflammation in autoimmune diseases while reducing side effects.

A sulfonium compound suppresses acid diffusion in ArF resist compositions, resolving the trade-off between transparency at 193 nm and manufacturing precision.

Hexafluoropropene dimerizes to perfluoro-4-methyl-2-pentene, isomerizes, and reacts with hydrazines to yield 5-fluoro-1H-pyrazoles.

Water-soluble stilbene prodrug forms convert in vivo to active agents that inhibit microtubule polymerization, reducing cardiac toxicity and neurotoxicity.

Difluoralkyl side chains on benzodithiophene cores boost conjugated polymer solubility for organic photovoltaic processing.

Chemoenzymatic modification of the parthenolide scaffold resolves the trade-off between structural complexity and ease of manufacture for anticancer agents.

Selective thiazole antagonist modulates adenosine A2A receptors, addressing efficacy and specificity limitations in anxiety disorder treatments.

Novel 2,6,7-substituted purine compounds act as HDM2 antagonists to disrupt protein interactions.

Ortho-ester substituted sulfonium salts eliminate benzene release and reduce yellowing while maintaining high reactivity in photocurable compositions.

Amino acid derivative plasticizers replace phthalates to eliminate environmental persistence and health risks via enhanced microbial decomposition.

A multi-step synthetic method produces fused heteroaromatic compounds using palladium catalysts and metal alkyl chalcogenides.

Allosteric targeting of DYRK1A avoids conserved ATP pockets, reducing CNS side effects while treating diabetes.

Dynamic control of acid concentration and solvent recycling minimizes waste while maximizing furfural purity.

Fluorine-modified zeolite catalysts boost pyridine and derivative yields while maintaining consistent catalytic activity across reaction cycles.

Polar aprotic solvents and ethanolamines prevent precipitation, ensuring stable inhibitor delivery with anhydrous ammonia.

An anthracene derivative host material increases electron density in organic light-emitting device layers.

Purifying ethyl-2-cyanoacrylate adhesive via deaeration and inactive gas injection at reduced pressure removes low-boiling-point impurities causing whitening.

A multi-step synthesis method for octane-boosting fuel additives using specific catalysts and reagents.

Sulfide-containing monoamide extractants rapidly pull palladium from acidic solutions into organic phases.

A reaction compound of alkaloid and phenol forms a stable chemical adduct that balances aerosol properties.

Simultaneous feeding into a continuous flow tubular reactor shortens reaction time and increases yield by reducing side reactions.

Segmented compound series with variable substituents optimize therapeutic efficacy while reducing drug development complexity.

Solid heterogeneous catalysts hydrate pyridine nitriles to amides while enabling continuous reactant and catalyst recycling.

A-B diblock copolymer particles integrate color generation and charge retention to resolve device complexity and prevent dye leaching in non-polar media.

Recombinant hosts produce adipyl-CoA intermediates using fatty acid O-methyltransferase and trans-enoyl-CoA reductase enzymes.

Developing a crystalline sulfate salt form resolves the trade-off between thermal stability and hygroscopicity for mu opioid receptor antagonists.

HDAC inhibitors convert immunosuppressive myeloid cells into tumor-fighting effectors, resolving persistent MDSC-mediated suppression in cancer therapy.

MYST family histone acetyltransferase inhibitors resolve the lack of effective therapeutic targets by selectively binding to KAT enzymes.

Chlorobenzene solvents eliminate hazardous byproducts during pyridine-3-sulfonyl chloride synthesis, resolving safety and purity trade-offs.

A bivalent compound links an ENL ligand to a degradation tag, recruiting E3 ubiquitin ligases to induce targeted protein breakdown.

Substituted porphyrazine dyes enhance light, ozone, and moisture fastness while preventing bronze phenomenon in cyan inkjet inks.

Formula I compounds replace TCE in vapor phase degreasing to remove grease while lowering environmental harm.

A scrubber uses a solvent and water mixture to recover propene from propane streams.

Nitrogen-containing dibenzofuran acceptors enable delayed fluorescence, resolving the stability trade-off against donor-acceptor strength.